PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Alto Marketing Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

IDBS Acquires InforSense to Provide End-to-End Solutions for Research & Development Data Management - IDBS, a leading provider of innovative data management solutions to multinational R&D organizations, today announced that it has concluded an unconditional agreement to acquire InforSense
IDBS Acquires InforSense to Provide End-to-End Solutions for Research & Development Data Management

 

NewswireToday - /newswire/ - Guildford, Surrey, United Kingdom, 2009/06/29 - IDBS, a leading provider of innovative data management solutions to multinational R&D organizations, today announced that it has concluded an unconditional agreement to acquire InforSense.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

IDBS, a leading provider of innovative data management solutions to multinational R&D organizations, today announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing award-winning scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.

R&D organizations in the public and private sectors rely upon their ability to capture, integrate and interpret their data. This is increasingly hampered by the explosion in volume and diversity of data available to scientists, the global scale of modern R&D activities and the requirement for data to be accessed and searched in context. InforSense’s rapid data integration technologies and web-based interactive analytics perfectly complement IDBS’ strong suite of secure, context-rich data management solutions. This transaction creates a unique supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.

With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine. The InforSense brand, its products and partnerships will continue to be vigorously developed, marketed and supported around the world.

IDBS (idbs.com), a private company headquartered in the UK and with offices worldwide, provides a range of scalable, secure and searchable data management solutions that support the collection, integration and retrieval of high value data. IDBS’ solutions are designed to manage highly diverse scientific data and processes, and are deployed to a broad customer base across a wide range of sectors including; life sciences, academia, consumer products, material sciences, food technology and energy; they are also used within regulated environments in both pharmaceuticals and manufacturing. IDBS’ solutions provide rigorous data storage and promote the collection of contextual data, which is required to make scientific data relevant and comparable. The company is a trusted partner of large multinational R&D companies and has been the regular recipient of numerous awards, including the Queen’s Award for Enterprise and Innovation.

InforSense is a private company with offices in London (UK), Boston (USA) and Shanghai (PRC), and was founded in 1999 to develop and commercialize pioneering technology in the fields of high performance computing, and large scale data mining, originally developed at Imperial College, London. InforSense’s core expertise lies in the development of high performance business and scientific intelligence and in web-based reporting applications that are highly differentiated from standard BI tools by their capacity, rapid implementation and configurability. InforSense applications provide the framework for integrating data from an extremely broad range of data sources, for many multinational organizations from pharmaceuticals to finance. InforSense has also developed state of the art applications to integrate genomics, biomarker and clinical data, that provide a unique offering to researchers in the developing areas of translational and personalized medicine. InforSense’s founder, Professor Yike Guo will take up the role of Chief Innovation Officer at IDBS.

Neil Kipling, CEO and founder of IDBS said, “IDBS has a powerful vision to provide complete data infrastructures for R&D organizations in commercial and academic endeavour. Our existing domain expertise and twenty-year track record is enhanced by the acquisition of InforSense, whose leadership and technologies are globally recognized. This is a major enabling step towards becoming the number one informatics partner of R&D worldwide. An additional facet of this acquisition is the opportunity to cement a strategic informatics research relationship with Imperial College. The combination of our rigorous software development and powerful new research capabilities creates a groundbreaking new organization.”

Mr John O’Connell, Chairman of InforSense said, “As Chairman I am delighted to see InforSense become part of a visionary software company with proven expertise in the life sciences domain. The market can only react positively to the emergence of the first single end-to-end R&D informatics solution provider. This acquisition has been enabled by the vision and commitment of founder and CTO, Professor Yike Guo, and by the strong leadership of our management team, under our CEO David Bennett, and is good news for InforSense customers, shareholders and staff".
This announcement comes shortly after IDBS announced the agreement with the University of Cambridge (UK) under which IDBS is to provide data management solutions to the Department of Chemistry, to improve data sharing across its broad network of academic groups in the UK and elsewhere, and marks the start of an ongoing informatics collaboration that will provide leading-edge technologies for commercialization.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Alto Marketing Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


IDBS Acquires InforSense to Provide End-to-End Solutions for Research & Development Data Management

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: David Robinson 
+44 1489 557672 davidr[.]alto-marketing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Alto Marketing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Alto Marketing Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)